Kazuya Murata Selected Research

Kazuya Murata Research Topics

Disease

7	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2016
7	Heart Failure 01/2021 - 12/2004
6	Tachycardia (Tachyarrhythmias) 01/2024 - 12/2020
6	Neoplasms (Cancer) 08/2018 - 10/2015
5	Atrial Fibrillation 01/2021 - 01/2019
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2003
3	Dementia (Dementias) 01/2022 - 11/2016
3	Hypertension (High Blood Pressure) 01/2021 - 05/2015
3	Fibrosis (Cirrhosis) 09/2020 - 02/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 05/2015
3	Alopecia (Baldness) 01/2018 - 01/2012
3	Contact Dermatitis (Eczema, Contact) 07/2014 - 10/2009
3	Inflammation (Inflammations) 02/2014 - 09/2006
2	Sarcopenia 01/2021 - 01/2019
2	Frailty 01/2021 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2019
2	Body Weight (Weight, Body) 01/2021 - 01/2019
2	Insulinoma 09/2019 - 01/2019
2	Pleural Effusion (Pleural Effusions) 09/2019 - 05/2016
2	Hyperglycemia 05/2015 - 03/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2014 - 02/2014
2	Hypersensitivity (Allergy) 07/2013 - 10/2009
2	Experimental Melanoma 01/2012 - 03/2009
1	Ventricular Tachycardia 03/2024
1	Cachexia 01/2023
1	Persistent Left Superior Vena Cava 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia) 01/2023
1	Obesity 01/2023
1	Weight Loss (Weight Reduction) 01/2021
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2021
1	Gliosis 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Insulin Resistance 01/2019
1	Neoplasm Metastasis (Metastasis) 05/2018
1	Intractable Pain 01/2018
1	Hyperalgesia 01/2018

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2015
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
3	Anti-Arrhythmia AgentsIBA 11/2022 - 12/2020
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 01/2018
3	VimentinIBA 01/2021 - 05/2017
3	Picryl Chloride (Trinitrochlorobenzene)IBA 07/2014 - 10/2009
2	Insulin (Novolin)FDA Link 01/2023 - 03/2014
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 05/2017
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021 - 01/2021
2	p38 Mitogen-Activated Protein KinasesIBA 09/2020 - 08/2014
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 05/2015
2	Cell-Free Nucleic AcidsIBA 01/2019 - 10/2015
2	HDL CholesterolIBA 01/2019 - 07/2013
2	ORALIT (ORS)IBA 01/2019 - 01/2019
2	Cadherins (E-Cadherin)IBA 02/2018 - 05/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2016 - 12/2004
2	LipopolysaccharidesIBA 08/2014 - 01/2010
2	CytokinesIBA 08/2014 - 07/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014 - 10/2009
2	GlycosidesIBA 07/2013 - 10/2009
2	flavanoneIBA 07/2013 - 10/2009
2	Messenger RNA (mRNA)IBA 10/2009 - 09/2006
2	Dobutamine FDA LinkGeneric 04/2003 - 02/2003
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	semaglutideIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Liraglutide FDA Link 01/2021
1	CanagliflozinIBA 01/2021
1	ipragliflozinIBA 01/2021
1	SodiumIBA 01/2021
1	Glycated Serum AlbuminIBA 01/2021
1	dapagliflozinIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	CollagenIBA 09/2020
1	SynaptophysinIBA 09/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	AlbuminsIBA 01/2019
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2019
1	LipidsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 08/2018
1	ChromatinIBA 02/2018
1	Zinc Finger E-box-Binding Homeobox 1IBA 02/2018
1	vexibinolIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	AndrogensIBA 01/2018

Therapy/Procedure

5	Catheter Ablation 03/2024 - 10/2019
2	Radiofrequency Ablation 12/2020 - 01/2019
2	Therapeutics 05/2018 - 01/2017
2	Ligation 01/2018 - 10/2009
2	Oral Administration 04/2010 - 01/2010
1	Glycemic Control 01/2023
1	Cryosurgery 01/2023
1	Activities of Daily Living (ADL) 01/2022
1	Resistance Training 01/2021
1	Combined Modality Therapy 01/2021
1	Renal Dialysis (Hemodialysis) 12/2020
1	Catheters 12/2020
1	Molecular Targeted Therapy 01/2019